Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Fabritiis

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|August 1, 1989
Prolonged effect of alpha-interferon after discontinuance of treatment in chronic myelogenous leukemia patientsG Alimena, E Montefusco, M Mancini, et al.
Bone Marrow Transplantation|January 1, 1990
Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapyG Meloni, P De Fabritiis, A M Carella, et al.
Leukemia & Lymphoma|September 1, 1993
Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cellsP De Fabritiis, C Dowding, J Bungey, et al.
Minerva Medica|February 15, 2011
[Mucositis in oncohematology]P Niscola, A Tendas, M Giovannini, et al.
Leukemia Research|January 1, 1991
CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtypeD Ferrero, N Carlesso, E Gallo, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
In vitro antitumor effect of LAK cells and alpha interferon in combination on tumor cell linesA Sandrelli, P De Fabritiis, G D Di Nucci, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantationA Busca, P de Fabritiis, V Ghisetti, et al.
Transplantation Proceedings|June 8, 2006
Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood unitsF Mancinelli, A Tamburini, A Spagnoli, et al.
Bone Marrow Transplantation|February 26, 1999
Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSFR Bellucci, M S De Propris, F Buccisano, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|August 1, 1989
Prolonged effect of alpha-interferon after discontinuance of treatment in chronic myelogenous leukemia patientsG Alimena, E Montefusco, M Mancini, et al.
Bone Marrow Transplantation|January 1, 1990
Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapyG Meloni, P De Fabritiis, A M Carella, et al.
Leukemia & Lymphoma|September 1, 1993
Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cellsP De Fabritiis, C Dowding, J Bungey, et al.
Minerva Medica|February 15, 2011
[Mucositis in oncohematology]P Niscola, A Tendas, M Giovannini, et al.
Leukemia Research|January 1, 1991
CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtypeD Ferrero, N Carlesso, E Gallo, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1992
In vitro antitumor effect of LAK cells and alpha interferon in combination on tumor cell linesA Sandrelli, P De Fabritiis, G D Di Nucci, et al.
Leukemia Research|January 1, 1986
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complementP De Fabritiis, M Bregni, J Lipton, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantationA Busca, P de Fabritiis, V Ghisetti, et al.
Transplantation Proceedings|June 8, 2006
Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood unitsF Mancinelli, A Tamburini, A Spagnoli, et al.
Bone Marrow Transplantation|February 26, 1999
Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSFR Bellucci, M S De Propris, F Buccisano, et al.
Pageof 6